14.06.2013 Views

3. Postere - rmr.medica.ro

3. Postere - rmr.medica.ro

3. Postere - rmr.medica.ro

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

150<br />

<st<strong>ro</strong>ng>3.</st<strong>ro</strong>ng><br />

ence, fasting plasma glucose and HbA1c. As<br />

we expected, the body and trunk adipose tissue<br />

percents were higher in the g<strong>ro</strong>up 2, but<br />

without statistical signifi cance.<br />

Fasting insulin and HOMA IR were positive-<br />

ly correlated with waist circumference, body<br />

mass index and body fat percent.<br />

Study on the paraoxonases: repercussions<br />

for ch<strong>ro</strong>nic metabolic diseases and<br />

athe<strong>ro</strong>scle<strong>ro</strong>sis risk<br />

Daniela Lixandru 1,2 , Irina Stoian 1 ,<br />

Bogdana Virgolici 1 , E.V. Bacanu 3 , Maria Mohora 1 ,<br />

Constanti n Ionescu-Tirgoviste 3<br />

1 Department of Biochemistry,<br />

University of Medicine and Pharmacy “Ca<strong>ro</strong>l Davila”,<br />

Bucharest, Romania<br />

2 Insti tute of Biochemistry of the Romanian Academy,<br />

Bucharest, Romania<br />

3“ N Paulescu” Nati onal Insti tute of Diabetes, Nutriti on<br />

and Metabolic Disease, Bucharest, Romania<br />

One of the st<strong>ro</strong>ngest risk factors for co<strong>ro</strong>nary<br />

heart disease (CHD) has p<strong>ro</strong>ved to be low plasma<br />

high-density lipop<strong>ro</strong>tein (HDL) concentration.<br />

HDL is subject to substantial compositional variations<br />

under both normal and pathological metabolic<br />

conditions.<br />

The antioxidant activity of HDL is largely due<br />

to the paraoxonase1 (PON1) located on it. Studies<br />

in the last two decades have demonstrated PON1<br />

ability to p<strong>ro</strong>tect against athe<strong>ro</strong>scle<strong>ro</strong>sis by hyd<strong>ro</strong>lyzing<br />

specifi c derivatives of oxidized choleste<strong>ro</strong>l<br />

and/or phospholipids in oxidized low-density lipop<strong>ro</strong>tein<br />

and in athe<strong>ro</strong>scle<strong>ro</strong>tic lesions. Signifi cant<br />

advances have been made in understanding the basic<br />

biochemical function of PON1 and the discov-<br />

REVISTA MEDICALÅ ROMÂNÅ – VOLUMUL LIX, NR. 2, An 2012<br />

Sex HOMA-IR<br />

G<strong>ro</strong>ups Women Men p<br />

G<strong>ro</strong>up 1<br />

HOMA-IR4<br />

p<br />

Age (years) 56.79±7.33 57.03±8.21 ns 58.51±5.92 56.47±7.30 ns<br />

Weight (kg) 87.07±1<st<strong>ro</strong>ng>3.</st<strong>ro</strong>ng>16 96.58±11.12 ** 86.83±12.89 89.62±11.38 ns<br />

BMI (kg/m2 ) 34.15±5.27 32.49 ±<st<strong>ro</strong>ng>3.</st<strong>ro</strong>ng>60 0.08 32.08±<st<strong>ro</strong>ng>3.</st<strong>ro</strong>ng>73 32.99±<st<strong>ro</strong>ng>3.</st<strong>ro</strong>ng>90 ns<br />

WC (cm) 108.54±11.24 109.90±7.62 ns 104.27±9.50 108.47±9.76 ns<br />

FPG (mg/dl) 152.63±41.87 130.79±37.51 0.02 130.65±3<st<strong>ro</strong>ng>3.</st<strong>ro</strong>ng>99 157.70±44.16 *<br />

HbA1c (%) 6.85±1.30 6.81±1.10 ns 6.46±1.04 6.97±1.37 0.09<br />

Fasti ng insulin (µU/ml) 15.59 ±8.32 12.40 ±5.16 * 8.11±2.84 18.24±6.47 **<br />

HOMA-IR<br />

index<br />

5.90±<st<strong>ro</strong>ng>3.</st<strong>ro</strong>ng>44 4.15±2.12 * 2.62±0.96 6.97±2.91 **<br />

Body adipose ti ssue<br />

percent (%)<br />

4<st<strong>ro</strong>ng>3.</st<strong>ro</strong>ng>48±4.64 29.62±5.71 ** 36.84±6.85 39.24±7.79 ns<br />

Trunk adipose ti ssue<br />

percent (%)<br />

40.48±5.84 3<st<strong>ro</strong>ng>3.</st<strong>ro</strong>ng>71±4.45 ** 36.08±5.36 38.56±6.96 ns<br />

ery of possible modulators of its activity. Recently<br />

two other members of the PON gene family, namely,<br />

PON2 and PON3 have also been reported to<br />

possess antioxidant p<strong>ro</strong>perties and may exhibit antiathe<strong>ro</strong>scle<strong>ro</strong>tic<br />

capacities as well. By this time is<br />

well know that paraoxonases are enzymes with<br />

three (paraoxonase, arylesterase and lactonase) activities<br />

which are inversely related to cardiovascular<br />

disease.<br />

This study consists in the comparative analysis<br />

of the PONs activity and the relevance for athe<strong>ro</strong>scle<strong>ro</strong>tic<br />

p<strong>ro</strong>cess. Is also present the implication of<br />

envi<strong>ro</strong>nmental factors and oxidative stress as well<br />

as the pozitiv corelation between PONs levels and<br />

degrees of metabolic disorders associated with athe<strong>ro</strong>scle<strong>ro</strong>sis<br />

like obesity and diabetes mellitus.<br />

Acknowledgement. Dr. D.L. was supported by<br />

the postdoctoral p<strong>ro</strong>gram POSDRU/89/1.5/S/60746,<br />

f<strong>ro</strong>m Eu<strong>ro</strong>pean Social Fund.<br />

Rolul stresului oxidati v în boala renală<br />

diabeti că<br />

Elena Violeta Băcanu 1 , Daniela Lixandru ²,<br />

Irina Stoian 2 , Bogdana Vîrgolici 2 , Maria Mohora 2 ,<br />

Constanti n Ionescu-Tîrgovişte 1<br />

1 Insti tutul Naţional de Diabet, Nutriţie şi Boli<br />

Metabolice ,,N.C. Paulescu“, Bucureşti , România<br />

²Universitatea de Medicină şi Farmacie ,,Ca<strong>ro</strong>l Davila“,<br />

Catedra de Biochimie, Bucureşti , România<br />

Int<strong>ro</strong>ducere<br />

Boala renală diabetică (BRD), defi nită ca o boală<br />

glomerulară p<strong>ro</strong>gresivă, de natură predominant infl<br />

a matorie, evoluează negativ în mediul diabetic.<br />

Scopul prezentului studiu a fost evaluarea statusului<br />

oxidativ/antioxidativ şi corelarea acestuia cu mar-

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!